| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5681588 | GLAXOSMITHKLINE LLC | Delayed release microtablet of β-phenylpropiophenone derivatives |
Oct, 2014
(9 years ago) | |
Rythmol Sr is owned by Glaxosmithkline Llc.
Rythmol Sr contains Propafenone Hydrochloride.
Rythmol Sr has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Rythmol Sr are:
- US5681588
Rythmol Sr was authorised for market use on 04 September, 2003.
Rythmol Sr is available in capsule, extended release;oral dosage forms.
The generics of Rythmol Sr are possible to be released after 28 October, 2014.
Drugs and Companies using PROPAFENONE HYDROCHLORIDE ingredient
Market Authorisation Date: 04 September, 2003
Treatment: NA
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
How can I launch a generic of RYTHMOL SR before it's drug patent expiration?
More Information on Dosage
RYTHMOL SR family patents
